It was reported that a control syringe component's line of spray "goes all over" instead of being a "controlled line of spray." at the time of the original report, the reporting facility confirmed that the reported problem/issue did not cause or contribute to any injuries.To date, no information has been received to indicate that a user or a patient experienced a death, serious injury, medical intervention, follow-up care, or other adverse health impact associated with the reported problem/issue.A sample was returned for evaluation and visual inspection identified no damage to the component.Functional testing was performed and no major abnormalities were observed with the flow of the component.In an abundance of caution, and in response to an fda 483 issued for cfn (b)(4) on 22-jan-2024, this medwatch is being filed for the reported problem/issue.If additional relevant information becomes available a supplemental medwatch will be filed.
|